| Sample | Title | Value | Rank |
|---|
| GSM549121 | patient 080, normal, homogenized [OPG study] | 4.8157 | 36 |
| GSM549102 | patient 115, normal, homogenized [OPG study] | 4.8865 | 37 |
| GSM549104 | patient 119, normal, homogenized [OPG study] | 4.73947 | 35 |
| GSM549108 | patient 138, normal, homogenized [OPG study] | 5.27367 | 45 |
| GSM549119 | patient 077, normal, homogenized [OPG study] | 5.06434 | 41 |
| GSM549133 | patient 032, cancer, homogenized [OPG study] | 4.91697 | 40 |
| GSM549139 | patient 042, cancer, homogenized [OPG study] | 4.82296 | 37 |
| GSM549099 | patient 107, normal, homogenized [OPG study] | 4.97682 | 39 |
| GSM549109 | patient 139, normal, homogenized [OPG study] | 5.21051 | 44 |
| GSM549110 | patient 046, normal, homogenized [OPG study] | 4.8028 | 36 |
| GSM549114 | patient 063, normal, homogenized [OPG study] | 4.84507 | 38 |
| GSM549122 | patient 082, normal, homogenized [OPG study] | 4.83744 | 37 |
| GSM549134 | patient 033, cancer, homogenized [OPG study] | 4.91759 | 39 |
| GSM549136 | patient 036, cancer, homogenized [OPG study] | 4.84126 | 38 |
| GSM549140 | patient 044, cancer, homogenized [OPG study] | 4.73846 | 35 |
| GSM549111 | patient 047, normal, homogenized [OPG study] | 4.57173 | 31 |
| GSM549113 | patient 057, normal, homogenized [OPG study] | 4.82378 | 38 |
| GSM549132 | patient 031, cancer, homogenized [OPG study] | 4.95894 | 40 |
| GSM549137 | patient 038, cancer, homogenized [OPG study] | 4.78472 | 36 |
| GSM549142 | patient 047, cancer, homogenized [OPG study] | 4.75635 | 32 |
| GSM549100 | patient 110, normal, homogenized [OPG study] | 5.35954 | 47 |
| GSM549107 | patient 135, normal, homogenized [OPG study] | 4.79846 | 37 |
| GSM549115 | patient 068, normal, homogenized [OPG study] | 4.92497 | 40 |
| GSM549116 | patient 072, normal, homogenized [OPG study] | 4.9277 | 39 |
| GSM549120 | patient 078, normal, homogenized [OPG study] | 4.85041 | 37 |
| GSM549131 | patient 030, cancer, homogenized [OPG study] | 4.73366 | 36 |
| GSM549118 | patient 074, normal, homogenized [OPG study] | 5.07352 | 42 |
| GSM549129 | patient 027, cancer, homogenized [OPG study] | 4.61439 | 31 |
| GSM549123 | patient 088, normal, homogenized [OPG study] | 4.95235 | 40 |
| GSM549124 | patient 006, cancer, homogenized [OPG study] | 4.87407 | 37 |
| GSM549126 | patient 015, cancer, homogenized [OPG study] | 4.78584 | 36 |
| GSM549128 | patient 025, cancer, homogenized [OPG study] | 4.64903 | 33 |
| GSM549103 | patient 117, normal, homogenized [OPG study] | 4.97827 | 38 |
| GSM549117 | patient 073, normal, homogenized [OPG study] | 4.82572 | 37 |
| GSM549138 | patient 041, cancer, homogenized [OPG study] | 4.66241 | 33 |
| GSM549141 | patient 045, cancer, homogenized [OPG study] | 4.80012 | 37 |
| GSM549130 | patient 028, cancer, homogenized [OPG study] | 4.82051 | 36 |
| GSM549101 | patient 111, normal, homogenized [OPG study] | 5.00007 | 39 |
| GSM549105 | patient 128, normal, homogenized [OPG study] | 4.97801 | 39 |
| GSM549106 | patient 134, normal, homogenized [OPG study] | 4.56983 | 32 |
| GSM549112 | patient 048, normal, homogenized [OPG study] | 5.131 | 43 |
| GSM549125 | patient 011, cancer, homogenized [OPG study] | 4.90978 | 38 |
| GSM549127 | patient 024, cancer, homogenized [OPG study] | 4.58756 | 31 |
| GSM549135 | patient 035, cancer, homogenized [OPG study] | 4.56976 | 32 |